Visual quantification of IC50 results from three independent experiments indicated that MAP2K2 knockdown increased ccRCC cell sensitivity to VEGFRi, while MAP2K2 overexpression enhanced resistance (Figure 3E, F). Here, MAP2K2 is linked to nonpapillary renal cell carcinoma.